OMX Nordic 40
2.347,19
PKT
-25,69
PKT
-1,08
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
08.04.22 | AstraZeneca Outperform | Credit Suisse Group | |
08.04.22 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
07.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
07.04.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
06.04.22 | AstraZeneca Buy | Deutsche Bank AG | |
06.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
05.04.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
05.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
05.04.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
05.04.22 | Volvo (B) Buy | Jefferies & Company Inc. | |
04.04.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
04.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
01.04.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.04.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
01.04.22 | Novo Nordisk Neutral | Credit Suisse Group | |
31.03.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
31.03.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
31.03.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
31.03.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
31.03.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
31.03.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
31.03.22 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
31.03.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
30.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
29.03.22 | Kone Buy | Jefferies & Company Inc. | |
29.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
29.03.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
29.03.22 | Kone Overweight | JP Morgan Chase & Co. | |
25.03.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
25.03.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
22.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.03.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
21.03.22 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
21.03.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
21.03.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
18.03.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
18.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
17.03.22 | Nokia Buy | Jefferies & Company Inc. |